Skip to navigation Skip to content



National MS Society Recognizes National Sponsors of Walk MS®

February 13, 2023

Each year, through the generous support of corporate partners, the National Multiple Sclerosis Society is able to fund critical research and services so that no one has to face MS alone. This year’s Walk MS national sponsors share in the Society’s commitment to finding a cure for every person living with MS.
Bristol Myers Squibb is proud to return for its fifth year as a national sponsor of Walk MS and supporter of the MS community.

EMD Serono returns for its fifth year as a national sponsor of Walk MS to showcase their support everyone affected by MS. 

Genentech continues to demonstrate their commitment to the MS community by returning for the eighth year as a Walk MS national sponsor.

Novartis proudly continues its long-time support of the MS community and Walk MS by returning as a national sponsor for the 12th consecutive year.

Sanofi returns for its seventh year nationally supporting Walk MS and the ‘Living with MS Program,’ which celebrates and honors the resilience of participants who live with the disease by linking them to resources, tools, and community to live their best lives.
Visit to find your local Walk MS event and get involved!

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.